Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Research ArticleClinical Sciences

Biodistribution, Dosimetry, and Clinical Evaluation of Technetium-99m Ethyl Cysteinate Dimer in Normal Subjects and in Patients with Chronic Cerebral Infarction

B. Leonard Holman, Robert S. Hellman, Stanley J. Goldsmith, Ismael G. Mena, Jean Leveille, Paolo Gerundini Gherardi, Jean-Luc Moretti, Angelika Bischof-Delaloye, Thomas C. Hill, Pierre M. Rigo, Ronald L. Van Heertum, Peter J. Ell, Udalrich Buell, Michel C. De Roo and Robert A. Morgan
Journal of Nuclear Medicine June 1989, 30 (6) 1018-1024;
B. Leonard Holman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert S. Hellman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stanley J. Goldsmith
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ismael G. Mena
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean Leveille
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paolo Gerundini Gherardi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean-Luc Moretti
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Angelika Bischof-Delaloye
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas C. Hill
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pierre M. Rigo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ronald L. Van Heertum
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter J. Ell
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Udalrich Buell
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michel C. De Roo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert A. Morgan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading
PDF extract preview

This is a PDF-only article. The first page of the PDF of this article appears above.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 30, Issue 6
June 1, 1989
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Biodistribution, Dosimetry, and Clinical Evaluation of Technetium-99m Ethyl Cysteinate Dimer in Normal Subjects and in Patients with Chronic Cerebral Infarction
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Biodistribution, Dosimetry, and Clinical Evaluation of Technetium-99m Ethyl Cysteinate Dimer in Normal Subjects and in Patients with Chronic Cerebral Infarction
B. Leonard Holman, Robert S. Hellman, Stanley J. Goldsmith, Ismael G. Mena, Jean Leveille, Paolo Gerundini Gherardi, Jean-Luc Moretti, Angelika Bischof-Delaloye, Thomas C. Hill, Pierre M. Rigo, Ronald L. Van Heertum, Peter J. Ell, Udalrich Buell, Michel C. De Roo, Robert A. Morgan
Journal of Nuclear Medicine Jun 1989, 30 (6) 1018-1024;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Biodistribution, Dosimetry, and Clinical Evaluation of Technetium-99m Ethyl Cysteinate Dimer in Normal Subjects and in Patients with Chronic Cerebral Infarction
B. Leonard Holman, Robert S. Hellman, Stanley J. Goldsmith, Ismael G. Mena, Jean Leveille, Paolo Gerundini Gherardi, Jean-Luc Moretti, Angelika Bischof-Delaloye, Thomas C. Hill, Pierre M. Rigo, Ronald L. Van Heertum, Peter J. Ell, Udalrich Buell, Michel C. De Roo, Robert A. Morgan
Journal of Nuclear Medicine Jun 1989, 30 (6) 1018-1024;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Metabolism of 99mTc-Ethylcysteinate Dimer in Infarcted Brain Tissue of Rats
  • Combined Diffusion and Perfusion MRI With Correlation to Single-Photon Emission CT in Acute Ischemic Stroke : Ischemic Penumbra Predicts Infarct Growth
  • Extracorporeal Rheopheresis in the Treatment of Acute Ischemic Stroke : A Randomized Pilot Study
  • Google Scholar

More in this TOC Section

  • Can Quantitative Renography Predict the Outcome of Treatment of Atherosclerotic Renal Artery Stenosis?
  • Estimation of Technetium-99m-MAG3 Plasma Clearance in Adults from One or Two Blood Samples
  • Nonimmunogenic Hyperthyroidism: Cumulative Hypothyroidism Incidence After Radioiodine and Surgical Treatment
Show more Clinical Sciences

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire